Clinical Trial

Dressing Methods in Inoperable Malignant Wounds

Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled study aimed to evaluate symptom burden and quality of life in oncology patients with inoperable malignant wounds. Patients were assigned to receive either polyhexamethylene biguanide (PHMB)-containing dressings or paraffin-based tulle dressings. Symptom severity and quality of life were assessed over a three-month follow-up period using standardized measures, including the Edmonton Symptom Assessment Scale (ESAS). The study primarily focuses on palliative outcomes rather than wound healing.
Trial Details
NCT Number NCT07556146
Lead Sponsor Sakarya University
Collaborators: Sakarya University Education and Research Hospital
Conditions Inoperable Malignant Wounds
Enrollment 31 participants
Start Date 2023-12-30
Primary Completion 2024-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-29